Nippon India Pharma Fund
Stocks held by month, last 12 months collected. Source: Nippon India Mutual Fund monthly portfolios.
| Stock | Change | Shares before | Shares now | Difference | Value |
|---|---|---|---|---|---|
| MOLBIO | New | — | 3.80 lakh | +3.80 lakh | ₹41.3 cr |
| CIPLA | Added | 37.95 lakh | 40.95 lakh | +3.00 lakh | ₹577 cr |
| MANKIND | Added | 14.04 lakh | 16.04 lakh | +1.99 lakh | ₹388 cr |
| GLAXO | Added | 9.29 lakh | 10.29 lakh | +1.01 lakh | ₹314 cr |
| ABBOTINDIA | Added | 74,802 | 78,126 | +3,324 | ₹202 cr |
| ANTHEM | Added | 10.59 lakh | 12.75 lakh | +2.17 lakh | ₹114 cr |
| BIOCON | Added | 20.04 lakh | 25.04 lakh | +5.00 lakh | ₹103 cr |
| SUNPHARMA | Trimmed | 62.06 lakh | 59.06 lakh | −3.00 lakh | ₹1,172 cr |
| DIVISLAB | Trimmed | 7.51 lakh | 7.01 lakh | −50,000 | ₹663 cr |
| THYROCARE | Trimmed | 40.17 lakh | 38.38 lakh | −1.79 lakh | ₹232 cr |
| EMCURE | Trimmed | 7.46 lakh | 6.41 lakh | −1.05 lakh | ₹119 cr |
| AKUMS | Trimmed | 14.05 lakh | 13.52 lakh | −53,611 | ₹105 cr |
Value: this month's market value in the AMC's file (an exit: last month's). "ISIN changed" = a split or bonus between the months; share counts are not comparable across it. Source: Nippon India Mutual Fund monthly portfolios.
| Sector | ||||
|---|---|---|---|---|
| SUNPHARMA Sun Pharmaceutical Industries Limited | Healthcare | 59.06 lakh | ₹1,172 cr | 12.37% |
| DIVISLAB Divi's Laboratories Limited | Healthcare | 7.01 lakh | ₹663 cr | 7.00% |
| LUPIN Lupin Limited | Healthcare | 27.84 lakh | ₹609 cr | 6.43% |
| CIPLA Cipla Limited | Healthcare | 40.95 lakh | ₹577 cr | 6.09% |
| APOLLOHOSP Apollo Hospitals Enterprise Limited | Healthcare | 5.49 lakh | ₹488 cr | 5.15% |
| DRREDDY Dr. Reddy's Laboratories Limited | Healthcare | 40.50 lakh | ₹468 cr | 4.93% |
| MANKIND Mankind Pharma Limited | Healthcare | 16.04 lakh | ₹388 cr | 4.09% |
| SAILIFE Sai Life Sciences Limited | Healthcare | 25.56 lakh | ₹373 cr | 3.94% |
| AJANTPHARM Ajanta Pharma Limited | Healthcare | 9.14 lakh | ₹329 cr | 3.47% |
| GLAXO GlaxoSmithKline Pharmaceuticals Limited | Healthcare | 10.29 lakh | ₹314 cr | 3.31% |
| MAXHEALTH Max Healthcare Institute Limited | Healthcare | 26.58 lakh | ₹277 cr | 2.92% |
| IPCALAB IPCA Laboratories Limited | Healthcare | 13.65 lakh | ₹270 cr | 2.84% |
| VIJAYA Vijaya Diagnostic Centre Limited | Healthcare | 16.72 lakh | ₹254 cr | 2.68% |
| MEDPLUS Medplus Health Services Limited | Consumer Services | 35.45 lakh | ₹238 cr | 2.51% |
| THYROCARE Thyrocare Technologies Limited | Healthcare | 38.38 lakh | ₹232 cr | 2.45% |
| GLAND Gland Pharma Limited | Healthcare | 8.01 lakh | ₹231 cr | 2.44% |
| PPLPHARMA Piramal Pharma Limited | Healthcare | 99.37 lakh | ₹213 cr | 2.25% |
| ABBOTINDIA Abbott India Limited | Healthcare | 78,126 | ₹202 cr | 2.13% |
| LALPATHLAB Dr. Lal Path Labs Ltd. | Healthcare | 10.01 lakh | ₹194 cr | 2.04% |
| ALKEM Alkem Laboratories Limited | Healthcare | 3.24 lakh | ₹173 cr | 1.82% |
| NH Narayana Hrudayalaya Ltd. | Healthcare | 8.24 lakh | ₹157 cr | 1.66% |
| AUROPHARMA Aurobindo Pharma Limited | Healthcare | 9.03 lakh | ₹155 cr | 1.63% |
| PFIZER Pfizer Limited | Healthcare | 3.18 lakh | ₹149 cr | 1.57% |
| SYNGENE Syngene International Limited | Healthcare | 35.01 lakh | ₹140 cr | 1.48% |
| SURAKSHA Suraksha Diagnostic Limited | Healthcare | 38.96 lakh | ₹132 cr | 1.39% |
| FORTIS Fortis Healthcare Limited | Healthcare | 13.46 lakh | ₹122 cr | 1.29% |
| EMCURE Emcure Pharmaceuticals Limited | Healthcare | 6.41 lakh | ₹119 cr | 1.25% |
| ANTHEM Anthem Biosciences Limited | Healthcare | 12.75 lakh | ₹114 cr | 1.20% |
| AKUMS Akums Drugs and Pharmaceuticals Limited | Healthcare | 13.52 lakh | ₹105 cr | 1.11% |
| BIOCON Biocon Limited | Healthcare | 25.04 lakh | ₹103 cr | 1.09% |
| SANOFI Sanofi India Limited | Healthcare | 3.00 lakh | ₹93.8 cr | 0.99% |
| SANOFICONR Sanofi Consumer Healthcare India Limited | Healthcare | 2.14 lakh | ₹88.5 cr | 0.93% |
| INDOCO Indoco Remedies Limited | Healthcare | 18.35 lakh | ₹44.7 cr | 0.47% |
| ASTRAZEN AstraZeneca Pharma India Limited | Healthcare | 62,568 | ₹43.5 cr | 0.46% |
| MOLBIO Molbio Diagnostics Limited | Healthcare | 3.80 lakh | ₹41.3 cr | 0.44% |
| CONCORDBIO Concord Biotech Limited | Healthcare | 1.12 lakh | ₹16.2 cr | 0.17% |
Equity rows as disclosed, Aug 2026. Source: Nippon India Mutual Fund monthly portfolio.
- Healthcare97.4%
- Consumer Services2.6%
AMFI's 22 sectors; one sector per stock, from the fund houses' industry labels. Source: Nippon India Mutual Fund monthly portfolio; AMFI.
- Mid Cap39.6%
- Large Cap31.2%
- Small Cap28.7%
- Not in AMFI's list0.4%
AMFI's list of Jun 2026. Source: Nippon India Mutual Fund monthly portfolio; AMFI.
| Period | Return | From | To |
|---|---|---|---|
| 1 year | +13.71 % in total | 25 Sep 2025 · NAV ₹566.9438 | 25 Sep 2026 · NAV ₹644.6841 |
| 3 years | +19.68 % a year, compounded | 25 Sep 2023 · NAV ₹375.9224 | 25 Sep 2026 · NAV ₹644.6841 |
| 5 years | +14.00 % a year, compounded | 24 Sep 2021 · NAV ₹334.6169 | 25 Sep 2026 · NAV ₹644.6841 |
| Since first NAV | +17.56 % a year, compounded | 2 Jan 2013 · NAV ₹69.8648 | 25 Sep 2026 · NAV ₹644.6841 |
Past performance may not be sustained in future.
Point-to-point change in the plan's NAV between the two dates shown, as AMFI publishes it; over a year, compounded a year. A period is shown only when a NAV exists within 7 days before its start date. Source: AMFI NAV files (plan code 118759).